Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Adenocarcinoma; Esophageal Neoplasms | Phase 2 | ClinicalTrials |
| Ovarian Neoplasms; Peritoneal Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Adenocarcinoma; Pancreatic Neoplasms | Phase 2 | ClinicalTrials |
| Adenocarcinoma | Phase 2 | ClinicalTrials |
| Mesothelioma | Phase 2 | ClinicalTrials |
| Pancreatic Neoplasms | Phase 2 | ClinicalTrials |
| Pancreatic Neoplasms | Phase 2 | ClinicalTrials |
| Pancreatic Neoplasms | Phase 2 | ClinicalTrials |
CONTENTS